Date | Insider | Price | Amount |
---|---|---|---|
12-8-2021 Insider Buy |
Steven S. Myers Director |
$0.89 CAGR » |
$30,190.28 33,785 shares |
9-9-2020 Insider Buy |
Michael H. Davidson Director |
$1.80 CAGR » |
$99,945.00 55,525 shares |
8-17-2015 Insider Buy |
David J. Mazzo Chief Executive Officer |
$1.40 CAGR » |
$27,922.00 20,000 shares |
8-12-2015 Insider Buy |
Robert S. Vaters President & CFO |
$1.35 CAGR » |
$16,681.36 12,385 shares |
8-11-2015 Insider Buy |
Robert S. Vaters President & CFO |
$1.24 CAGR » |
$100,172.70 81,000 shares |
Also See: Institutional Holders of CLBS
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 12/09/2021 | |
End date: | 09/14/2022 | |
Start price/share: | $0.90 | |
End price/share: | $0.43 | |
Dividends collected/share: | $0.00 | |
Total return: | -52.22% | |
Annualized Gain: | -68.57% | |
Starting investment: | $10,000.00 | |
Ending investment: | $4,778.00 | |
Years: | 0.76 |
Caladrius Biosciences Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Caladrius Biosciences insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding CLBS
Free CLBS Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |